Home/Filings/4/0001209191-21-030526
4//SEC Filing

Chen Daniel ShinYu 4

Accession 0001209191-21-030526

CIK 0001496323other

Filed

May 4, 8:00 PM ET

Accepted

May 5, 9:30 PM ET

Size

9.2 KB

Accession

0001209191-21-030526

Insider Transaction Report

Form 4
Period: 2021-05-03
Chen Daniel ShinYu
Chief Medical Officer
Transactions
  • Exercise/Conversion

    Stock Option (right to buy)

    2021-05-03950343,040 total
    Exercise: $1.39Exp: 2028-12-30Common Stock (950 underlying)
  • Tax Payment

    Common Stock

    2021-05-03$68.03/sh481$32,722116,987 total
  • Exercise/Conversion

    Common Stock

    2021-05-03$1.39/sh+950$1,321117,468 total
Footnotes (3)
  • [F1]The option exercise was effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person.
  • [F2]Represents shares withheld by the Issuer to pay the exercise price and taxes pursuant to the "net exercise" of 950 option shares.
  • [F3]The option, originally for 361,090 shares, of which 18,050 shares have been exercised, vested as to 1/4 of the shares on August 1, 2019, and an additional 1/48 of the shares subject to the option shall vest monthly thereafter, subject to the Reporting Person remaining a service provider through each such date.

Issuer

IGM Biosciences, Inc.

CIK 0001496323

Entity typeother

Related Parties

1
  • filerCIK 0001787681

Filing Metadata

Form type
4
Filed
May 4, 8:00 PM ET
Accepted
May 5, 9:30 PM ET
Size
9.2 KB